Global Astigmatism Market Drivers, Segmentations, Key Players, Analysis & Forecast 2022

 Astigmatism is the situation in which patient suffered with blurred vision. It is a refractive error condition in which eyes not able to focus light evenly onto the retina. Normally astigmatism is occurring with condition like myopia and hyperopia, these both condition causes refractive errors because they affect how the eyes bend or "refract" light. It can be diagnosed by eye exam, and treatment depend upon the condition of astigmatism. There are two treatments are available for the common levels of astigmatism that are corrective lenses and refractive surgery. According to American Academy of Ophthalmology, in the United States 1 in 3 people may suffer with astigmatism and it may occur in combination with near- or farsightedness. Also, according to a report published by the Centers for Disease Control and Prevention in 2015, Around 11 million population of Americas of age 12 years and above improve their vision through proper refractive correction and more than 3.3 million Americans aged 40 years and older are either legally blind or are with low vision.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1734  

Global Astigmatism Market – Overview

The global astigmatism market is showing the significant growth; mainly due to increase in the ageing population, eye injury, eye disease, and surgery. Companies are showing much interest toward the astigmatism market, as they feel there are huge opportunities and gaps between the market demand and supply of effective treatments. Thus, companies are showing more interest in research and development activities for introducing best treatment that meets the requirement of market. The development has been made by Novartis AG in 2017, Alcon is the division of Novartis and consider as a global leader in eye care, introduce AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery. Also, in 2018, Johnson & Johnson Vision announced the launch of expanded parameters for 1-DAY ACUVUE MOIST Brand Contact Lenses for astigmatism in the United States. These inventions help companies to meet the requirement of the market and maximize the profit share across the globe. Moreover, in 2017, Bausch & Lomb Incorporated division of Valeant Pharmaceuticals International, Inc. introduce Biotrue ONEday for Astigmatism daily disposable contact lenses in 20 countries of Europe. Novartis AG and Johnson & Johnson are trying to feel the gap along with market players such as SeaVision USA, Bausch & Lomb Incorporated, CooperVision, Inc., Orion Vision Group.

Global Astigmatism Market   - Regional Analysis

The market of astigmatism is much higher in the Americas region. There are several factors for tremendous growth of the astigmatism market in this region such as growing ageing population, presence of major market players, and increasing awareness about astigmatism. According to reports published by the Centers for Disease Control and Prevention in 2015, Around 1.8 million Americans aged 40 years and above are affected by AMD and an additional 7.3 million with large drusen are at substantial risk of developing AMD.

Europe is also considering the huge market for astigmatism players, owing to present of the huge ageing population. Moreover, the population within the reason are more aware about the healthcare in comparison to another region like Asia Pacific and The Middle East and Africa.

Asia Pacific and the Middle East and Africa region are considering the big opportunity for the market players owing to the presence of the high patient population. Whereas country like India and china of Asia Pacific region are considering fastest growing region owing to the presence of active government towards health care. These countries are open to adopt new treatment from developing countries in order to improve the quality of life for their citizen. Japan is a well-developed country and have well established healthcare system and technology, whereas developing countries are still focusing on new technology, which lead to increase in the demand for various astigmatism treatment. Most of the countries of these regions such as India and China are investing more into research and development activity for introducing better treatment at nominal price.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/astigmatism-market-1734 

Bio-Process Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2022

 Overview:

The global bio-process technology market to experience significant growth during the forecast period (2017-2022), reports Market Research Future (MRFR) in an elaborate study. The technology allows the derivation of living cells or their components to utilize it in a vast array of treatments to attain the planned result. Healthcare sector has been experiencing some significant revamping owing to such advanced technology, and the market is touted to experience the benefits during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2095 

Drivers and Restraints:

The spurring market has drivers in diverse sectors such as healthcare, food processing, biomedical devices, pollution, and global warming. In commercial biotechnology, it is used in the production of enzymes and antibiotics which is gaining traction continually. Vaccinations for several chronic diseases have also generated considerable demand for the technology.

Food processing is also a sector that is developing rapidly owing to changes made in lifestyle triggered by rapid urbanization and industrialization. Various nutritional supplements are the result of the introduction of such technology and are assisting the commoners in leading a healthier life.

The technology is also a possible answer for sustainable resource management. Wastewater management is an area where its impact is convincing, and it can work wonder in contaminated sites as well. Petroleum sector can also benefit much as the growing demand for biofuels can give the market essential momentum.

However, the regulatory process often delays the productional procedure which can be considered to be a market deterrent. But its multifarious application can help it maintain steady traction in the market.

Industry News:

In late 2017, Novartis’ Kymriah and Gilead/ Kite Pharma’s Yescarta, two cell-therapy biotherapeutic medicine got approved which came as excellent news to cell therapy which got significant boost from monoclonal antibody industry.  

Segmentation:

The global bio-process technology market can be segmented by type, application, and end-users.

Type-based segmentation includes cell culture, cell expansion, flow cytometry, cell line development and virus infiltration. Cell culture is a segment that is enjoying popularity across the world owing to its diverse application in various sectors. The segment is spearheading the market due to its necessity in treating multiple chronic diseases.

Application-wise, the market comprises biopharmaceuticals, specialty products, industrial chemicals and environment management aid. Biopharmaceuticals are prospering much as various medicines used in curing several diseases ranging from the most common ones to chronic diseases are products of such technological advancements. Furthermore, petrochemicals are going to boost the demand for industrial chemicals in the coming years.

Based on end-users, the market consists hospitals, research labs and centers, medical institutions and others. With increasing government and private funding, research labs and centers are extensively investing themselves in developing new products that can take various associated industries miles ahead.

Regional Analysis:

Region-wise, the market comprises namely North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America is currently leading the market in terms of generating revenue. Academic researches and extensive sales of biopharmaceutical products are contributing much to the progress of the region. Well-developed manufacturing facilities and research laboratories in countries such as the U.S. and Canada are proving beneficial for the market.

The APAC is expected to become the fastest growing region during the forecast period. Rising population and the integration of advanced technologies in the healthcare sector are impacting the market significantly. The biotechnology industry is also expanding at a considerable rate.

Market Dashboard:

The market is growing competitive, and the companies are extending their portfolio by going into mergers and acquisitions. For instance, Charles River Laboratories has recently acquired MPI Research, a remarkable organization of this field. Thermo Fisher Scientific, Inc. recently signed an agreement with Roper Technologies to acquire Gatan.

Key players of the market profiled in this report are Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/bio-process-technology-market-2095 

3D Printing Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2020 - 2023

 Market Overview

3D printing functions an essential part of the medical and dental manufacturing sector and is the preferred choice of medical device manufacturers, for its cost-effective production of all types of medical devices such as the custom-made knee, hearing aids, hip implants, and prostheses.

Global 3D printing medical devices market is anticipated to grow due to influential factors such as the increase in investment by the growing use of 3D printing device in the healthcare industry the governments towards the healthcare sector, rising technological advancements in 3D printing, and easy production of medical devices.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6830 

According to a report issued by Market Research Future (MRFR), the global 3D printing medical devices market has been assessed to grow at a CAGR of 18% during the forecast period from 2018 to 2023.

Segmental Analysis

The global market for 3D printing medical devices has been segmented into types, component, technology, application, end-users, and regions.

Based on types, the global 3D printing medical device market has been segmented into prosthetics & implants, surgical guides, surgical instruments, and tissue engineering product. The surgical guide segment has been assessed to account for the largest market share in the type segment over the forecast period, due to its advantage of providing accurate implant restoration, resulting in a rise in the demand for the surgical guide has been increasing, and this is a crucial factor driving the growth of this market segment.

Based on the component, the market for 3D printing medical devices has been segmented into the 3D bioprinter, 3D printer, materials, software & services, and system. Software & services segment is projected to account for the largest market share in the component segment over the forecast period, due to the increase in advancements in the software solutions for manufacturing high-quality 3D-printed medical products.

On the basis of technology, the 3D printing medical device market has been segmented into 3D printing, droplet deposition, electron beam melting (EBM), laminated object manufacturing (LOM), laser beam melting, photopolymerization, poly-jet technology, and others. Photopolymerization segment has been assessed to account for the largest market share in the technology segment over the forecast period.

Based on application, the global market for 3d printing medical device has been segmented into clinical study devices, external wearable devices, implants, and tissue engineering. The external wearable devices segment assessed to account for the largest market share in the application segment over the forecast period.

By end-users, the market has been segmented into academic institutions, contract research organization, hospitals, medical and surgical centers, and pharma and biotech companies. The medical and surgical centers segment has been assessed to account for the largest market share in the end-user segment over the forecast period, due to the increase in the patient population and decrease in surgical and infection risks.

Based on the region, the market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Key Players

The key players identified in the global 3D printing medical devices market are 3D Systems Corporations, 3T RPD Ltd., Arcam AB, Bio3D Technologies, EnvisionTEC, Cyfuse Medical K.K.EOS GmbHConcept, Laser GmbH, Materialise NV, Organovo Holdings, Inc., Oxford Performance Materials, Inc., Renishaw plc, Prodways Group, Stratasys Ltd., and SLM Solutions Group AG.

Regional Analysis

North America has been expected to dominate the global 3D printing medical device market over the forecast period, due to the growth in the demand for organ transplant surgeries in the region, and the increase in investments made by the government towards the research and development of advanced 3D printing technologies.

Europe is the second-largest regional market for 3D printing medical devices, owing to favorable government investments, rise in research and development. Additionally, the changing lifestyles of consumers have led to an increase in patient population and number of surgeries, consequently contributing to the growth of the 3D printing medical device market in the region.

Asia-Pacific has been assessed to grow as the fastest-growing region in the 3D printing device market through the forecast period, due to the growing prevalence of chronic diseases such as diabetes, blood pressure disorders among others, the increasing investments in the healthcare sector by the government, and increase in the geriatric population.

The Middle East & Africa region has been accounted for the comparatively smallest market share in the global 3D printing medical devices market owing to a healthcare sector that needs improvement, lack of medical knowledge, and inadequate medical facilities.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830 

Dental 3D Printing Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2020 - 2023

 Market Highlights

Dental 3D printing is used to produce customized designs for various categories of dental products such as dental implants, dental braces, crown, and bridges. Moreover, 3D dental printing involves the combination of CAD/CAM technology, oral scanning, designing, and 3D printing. The increasing incidence of dental caries and other dental-related diseases, growing demand for cosmetic dentistry, rising geriatric population, and increasing adoption of dental 3D printers in hospitals and clinics are anticipated to drive the growth of the market during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6260 

However, unfavorable reimbursement scenario and stringent government regulation for approval of 3D printing equipment may hamper the growth of global dental 3D printing market during the assessment period.

The global dental 3D printing market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold its market position. For instance, in May 2017, Stratasys Ltd., a 3D printing, and additive manufacturing solutions company introduced Stratasys J700 Dental 3D Printing Solution for orthodontics.

Regional Analysis

The market in the Americas is expected to dominate the global dental 3D printing market during the forecast period owing to the rising demand for cosmetic dentistry, increasing oral care expenditure, and rising popularity of digital dentistry among the people. Additionally, the growing occurrences of dental caries and tooth loss associated with the aging population are anticipated to boost the growth of the market in this region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the growing incidence of dental-related problems. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the assessment period owing to growing disposable income, increasing incidence of dental caries, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global dental 3D printing market. The market growth in this region can be attributed to increasing healthcare expenditure and developing healthcare infrastructure.

Segmentation

The global dental 3D printing market has been segmented into product and service, technology, application, and end-user.

The market on the basis of product and service has been segmented into equipment, materials, and services. The equipment segment has been segmented into dental 3D scanners and Dental 3D printers. The materials segment has been segmented into plastic, metal, and other materials.

The market on the basis of technology has been segmented into vat Photopolymerization, fused deposition modeling, polyjet technology, selective laser sintering, and other technologies. The vat Photopolymerization has been further segmented into stereolithography and digital light processing.

The market, by application, has been segmented into prosthodontics, orthodontics, and implantology.

On the basis of end-user, the market has been segmented into dental laboratories, dental hospitals and clinics, dental academic and research institutes.

Key Players

Some of the key players in the global dental 3D printing market are Stratasys Ltd., 3D Systems, Inc., EnvisionTEC, Inc., DWS Systems, Renishaw Plc., Formlabs, Prodways group, SLM Solutions Group, Carbon, Inc., Concept Laser GmbH, EOS GmbH Electro Optical Systems, Rapid Shape GmbH, Asiga, and  Roland DG.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-3d-printing-market-6260 

Textile Implants Market 2020 Global Dynamics, Trends, Opportunities, Drivers, Challenges And Influence Factors Shared In A Latest Report

 Market Highlights

Textile implants are used in Hernia repair products nerve conduits, cardiovascular plugs, heart valve sewing cuffs, collapsible orthopedic anchors, diabetic wound care tissue scaffolds, osteoconductive bone grafts, scoliosis correction devices, suture loops, sternal closure devices, partially to fully resorbable soft tissue repair products, drug and device combination products. The market is driven by the increasing prevalence of sports injuries and orthopedic surgeries, rising prevalence of cardiovascular diseases, increasing prevalence of breast and prostate cancer and technological advancements in textile implants, rising geriatric population, increasing research on textile implants, and increasing preference for minimally invasive surgeries. However, factors such as high procedure costs, unfavorable reimbursement policies, loss of tensile strength and product recall or failure are expected to restrict the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6231 

Segmentation

The global textile implants market is segmented on the basis of product type, systems, and end-user. The textile implants market, by product type categorized into 2D implantable forms, 3D implantable forms, natural textile implants and synthetic textile implants. The synthetic textile category includes polyamide, polyester, polyethylene, polypropylene, resorbable polymers and non-resorbable polymers. Application segment is segmented into hernia repair products, cardiovascular, sports medicine, diabetic wound care, ophthalmology, and breast reconstruction. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others.     

Regional Analysis

The Americas is expected to dominate the textile implants market during the forecast period. The rise in the occurrence of cardiovascular diseases drives the market in this region. Textile implants (graft and stent) are used to replace the diseased artery. According to the American Heart Association 2017, 45.1% of the cardiovascular disease deaths in the U.S. were due to Coronary Heart Disease (CHD). This influences the market growth during the forecast period.

 Europe (UK, Belgium, France, & Netherlands) is second in the market owing to the increasing accidents and injuries and growing healthcare expenditure. According to the Eurostat in 2014, 152 thousand deaths in Europe were due to accidents and injuries.

Asia Pacific is expected to observe growth for the global textile implants market owing to increasing prevalence of breast cancer, rising geriatric population and rising preference for minimally invasive procedures. According to the General Re Corporation in 2016, 404,000 cases of breast cancer were diagnosed in Asia, with the highest incidence rates in China, Japan, and Indonesia.

Thus, providing favorable backgrounds for the market to grow.

The Middle East and Africa accounts for least share due to Technical complexity, high cost, stringent government policies and low per capita income.

Key Players

Some of the key players for the global textile implants market are SERAG-WIESSNER GmbH & Co. KG Zum Kugelfang, LARS (France), Johnson and Johnson,  Neoligaments (UK), Surgicraft Inc., Cousin Biotech (France), Xenotech, Orthomed S.A.S. (France), WL Gore, FX Solutions (France), Aran Biomedical, Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland) and other.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/textile-implants-market-6231 

Injection Pen Market 2020 Covers Global Industry Share, Size, Gross Margin, Future Trends, Demand, Business Insight By Leading Key Players Forecast Till 2023

 Market Highlights

The injection pen is a standard delivery device for accurate subcutaneous delivery. A number of factors such as increasing prevalence of chronic diseases, ongoing technological advancements, and improving regulatory framework are fueling the growth of the global injection pen market. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population were suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.

Moreover, technological advancements in injection pens and increasing product launch by prominent players are likely to drive the market growth during the forecast period. For instance, in 2017, Sanofi launched AllStar pro reusable pen injector across the European market.  Furthermore, the increasing application of injection pen in the treatment of various chronic diseases, lifestyle diseases and infertility problems enhance the market growth. Additionally, in November 2017, Merck announced the approval of its new GONAL-f RFF Redi-ject (follitropin alfa injection) prefilled pen by the U.S. FDA.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6146 

However, certain issues such as reimbursement issues in the developing nations and presence of alternative drug delivery devices can hamper the growth of the market.

Regional Analysis

The Americas is likely to dominate the global injection pen market owing to the increasing prevalence of cancer and diabetes in the population during the forecast period. In addition, well-established healthcare sector, favorable reimbursement scenario, and growing number of regulatory approvals further drive the growth of the market. According to the WHO, in 2016, 9.6% of total America population were suffering from diabetes. Europe is likely to hold the second position in the global injection pen market. The market growth is attributed to the availability of funds for research, increasing prevalence and government support for research and development. The Asia Pacific is the fastest growing market owing to the huge patient pool with chronic diseases and increasing healthcare expenditure. For instance, according to the WHO (2016), in China, 10% of adults were diagnosed with diabetes. It also stated that type 2 diabetes was found to be the most prevalent type of diabetes in China. The Middle East and Africa injection pen market are expected to grow slowly during the forecast period. Moreover, in this region, Middle East accounts for largest share owing to the increasing presence of prominent market players in the recent years.

Segmentation

The global injection pen market is segmented on the basis of the type, product, therapy, distribution channel, and end users. On the basis of the type, the market is classified into disposable injection pens and reusable injection pens. The global injection pen market on the basis of product is segmented into insulin pens and pen needles. On the basis of the therapy, the market is segmented as diabetes, growth hormone therapy, fertility, osteoporosis, multiple sclerosis, cardiovascular diseases, rheumatoid arthritis, obesity, Crohn’s disease, cancer, and others. Diabetes is further segmented into insulin and GLP-1.On the basis of distribution channel is segmented into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics. On the basis of end users, the global injection pen market is segmented into home care and hospitals & clinics.

Global Injection Pen Key Players

Some the prominent players in the global injection pen market are  Novo Nordisk (Denmark), Eli Lilly (U.S.), Sanofi (France), Merck (U.S.), Ypsomed (Switzerland), AstraZeneca (U.K.), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (U.K.), Novartis (Switzerland), Pfizer (U.S.), Haselmeier (Switzerland), Jiangsu Delfu medical device Co. Ltd (China), and Biocon Ltd (India).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/injection-pen-market-6146 

Medical Bionic Implant/Artificial Organs Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2020 - 2023

 Market Highlights

Bionic implants are artificially engineered devices that are implanted into a human to replace a natural organ. The main purpose of bionic implants is to provide life support to prevent imminent death while awaiting a transplant and improve the patient's ability to interact socially.

A number of factors such as the increasing cases of organ failure, technological advancements, rising cases of accidents and injuries, improving regulatory framework, increasing government assistance, and increasing prevalence of eye diseases are propelling the growth of the global medical bionic implant/artificial organs market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6051 

However, lack of skilled professionals and the high cost of devices and poor healthcare system in low and middle-income countries may hamper the growth of the market.

It is estimated that the medical bionic implant/artificial organs market is expected to register a CAGR of 7.0% during the forecast period of 2018–2023.

Regional Analysis

The Americas dominates the medical bionic implant/artificial organs market owing to the presence of major market players and high adoption rate of medical bionic implants. On November 02, 2017, Second Sight Medical Products, Inc. received the U.S. FDA approval to initiate Orion Cortical Visual Prosthesis System (Orion) feasibility clinical study. In 2013, the company won the FDA approval for Argus II retinal prosthesis system.

Europe holds the second position in the Medical Bionic Implant/Artificial Organs market. It is expected that the government support towards research and development expenditure and rising prevalence of hemophilia and related complications are likely to drive the European market.

Asia Pacific is the fastest growing medical bionic implant/artificial organs market owing to a huge patient pool, increasing demand for advanced treatments, and development in the healthcare technology. Healthcare expenditure is found to be improving in Asia Pacific. According to the data suggested by the Australian Institute of Health and Welfare during the year 2015 to 2016, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure during 2014 to 2015.

The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Segmentation

The global medical bionic implant/artificial organs market is segmented on the basis of technology, product, fixation, and end-user.

On the basis of technology, the market is classified as mechanical bionics and electronic bionics.

By product, the market is classified as vision bionics, ear bionics, orthopedic bionics, heart bionics, neural/brain bionics, and others. Vision bionics are further segmented as bionic eye and others. Ear bionics are further segmented as cochlear implant and Bone Anchored Hearing Aid (BAHA). Orthopedic bionics are further segmented as bionic hand, bionic leg, bionic finger, exoskeleton, and electrical bone growth stimulators. The sub-segments of bionic leg include bionic knee and bionic feet. The sub-segments of electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are further segmented as pacemaker, total artificial heart, ventricular assist device, and artificial heart valve. The sub-segments of pacemaker include implantable cardiac pacemaker and external pacemaker. The sub-segments of artificial heart valve include mechanical heart valve and tissue heart valve. Neural/brain bionics are further segmented as deep brain stimulators, vagus nerve stimulator, and spinal cord stimulators.

By fixation, the market is segmented into implantable and externally worn.

By end-user, the market is segmented into hospitals and clinics, research and academic institutes, and others.

Key Players

Some of key the players in the global medical bionic implant/artificial organs  market are Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051